The levels of biomarkers of endothelial dysfunction and atherosclerosis, such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), are increased in the serum of patients receiving hemodialysis [6]. This evidence concerns the gene VCAM1 and atherosclerosis.